| Sherrell Monique Forston, PA C | |
|
165 N Park Trl, Suite 100, Stockbridge, GA 30281-6500 | |
| (770) 506-1800 | |
| (770) 389-5947 |
| Full Name | Sherrell Monique Forston |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 165 N Park Trl, Stockbridge, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518923218 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Sherrell Monique Forston, PA C 165 N Park Trl, Suite 100, Stockbridge, GA 30281-6500 Ph: (770) 506-1800 | Sherrell Monique Forston, PA C 165 N Park Trl, Suite 100, Stockbridge, GA 30281-6500 Ph: (770) 506-1800 |
News Archive
Vical Incorporated today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $2.25 per share. The gross proceeds to us from this offering are expected to be approximately $33.8 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by us. The offering is expected to close on or about September 29, 2010, subject to customary closing conditions.
Despite cancer survival rates increasing dramatically for children and older adults in the last 20 years, there has been minimal improvement in the survival rates in the Adolescent and Young Adult (AYA) population, an age range defined as 15 – 29 years by the presenters.
Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that the Federal Trade Commission (FTC) has accepted a proposed consent order for public comment relating to Watson's pending acquisition of privately held Arrow Group and has granted early termination of the Hart Scott Rodino waiting period, thereby permitting the parties to close the transaction.
Women with major depression should be monitored for emerging symptoms of hypomania during the postpartum period, say researchers.
Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.
› Verified 9 days ago
Charles Everett Coppinger, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1492 Hudson Bridge Rd, Stockbridge, GA 30281 Phone: 404-255-1933 Fax: 404-553-9830 | |
James Vincent Edwards, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1240 Eagles Landing Pkwy Ste 300, Stockbridge, GA 30281 Phone: 770-506-4350 Fax: 770-506-9860 | |
Janet Holland, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 175 Country Club Dr, Bldg. 100 Suite C, Stockbridge, GA 30281 Phone: 770-507-1414 Fax: 770-507-5150 | |
Michael C. Martin, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 145 Eagles Walk, Suite A, Stockbridge, GA 30281 Phone: 770-914-0116 Fax: 770-914-7703 | |
Charla V Johnson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 950 Eagles Landing Pkwy, Suite 212, Stockbridge, GA 30281 Phone: 404-307-3062 | |
Elizabeth Matheny Wolfe, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 404-367-3014 | |
Jerrica Miles, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1240 Eagles Landing Pkwy Ste 300, Stockbridge, GA 30281 Phone: 770-506-4350 |